RxDoctor Payments Data

Patricia Gutowski, APRN

Family · Manhattan, KSNPI 1720610066

Payments from drug & device makers

$839in general payments, 2019–2025

Across 39 payments — averaging $21.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Travere Therapeutics, Inc.$272
  • AstraZeneca$144
  • Vifor Pharma, Inc.$74
  • Ardelyx, Inc.$68
  • Bayer$66
  • Boston Scientific$44
  • plus $171 from 7 others

What the payments were for

  • Travel & lodging$111%
  • Food & beverage$82899%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$839 in reported general payments places this provider in the 70th percentile of 1,579 family providers in Kansas.

See all family providers in Kansas

Medicare billing

Part B allowed, 2024
$16,868
Medicare patients
145
Services billed
179

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol73$64,024
JardianceEmpagliflozin51$42,105
VeltassaPatiromer Calcium Sorbitex16$23,866
Sevelamer Carbonate12$5,200
Calcium Acetate33$2,893
Allopurinol109$653
Tamsulosin Hcl57$633
Tacrolimus11$628
Losartan Potassium58$491
Calcitriol21$485
Terazosin Hcl18$425
Metolazone24$371
Furosemide109$314
Lisinopril130$308
Potassium Chloride18$248

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$144$64,02473 claims
Boehringer IngelheimJardiance$22$42,10551 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,579 family providers in Kansas.

Other family in Manhattan

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →